Skip to Content
Merck
  • Quality of the voice after injection of hyaluronic acid into the vocal fold.

Quality of the voice after injection of hyaluronic acid into the vocal fold.

Medical science monitor : international medical journal of experimental and clinical research (2013-04-18)
Agata Szkiełkowska, Beata Miaśkiewicz, Marc Remacle, Paulina Krasnodębska, Henryk Skarżyński
ABSTRACT

Voice disorders resulting from glottic insufficiency are a significant clinical problem in everyday phoniatric practice. One method of treatment is injection laryngoplasty. Our study aimed to assess the voice quality of patients treated with hyaluronic acid injection into the vocal fold. We studied 25 patients suffering from dysphonia, conducting laryngological and phoniatric examination, including videostroboscopy and acoustic voice analysis, before the operation and 1, 3, and 6 months later. In all cases there was complete or almost complete glottic closure after the operation. One month after the procedure, videostroboscopic examination revealed reappearance of vocal fold vibration in 8 cases; after 3 months this had risen to 15 cases. Perceptual voice quality (as assessed by the GRBAS scale) in patients with glottic insufficiency was improved. The most significant improvement was obtained 1 month after surgery (p=0.0002), and within the next months further statistically significant improvements (p=0.000002) were noted. Multidimensional voice analysis showed statistically significant and rapid improvement in frequency parameters, especially vFo. Other parameters were also improved 3 and 6 months after surgery. Injection of hyaluronic acid into the vocal fold improves phonatory functions of the larynx and the quality of voice in patients with glottic insufficiency. It may be a safe and conservative method for treatment of voice disorders. Hyaluronic acid injection to the vocal fold is an easy, effective, and fast method for restoration of good voice quality.

MATERIALS
Product Number
Brand
Product Description

Sodium hyaluronate, BRP, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Hyaluronic acid sodium salt from bovine vitreous humor
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 70,000-120,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 120,000-350,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 50,000-70,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 15,000-30,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 8,000-15,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,000,000-1,250,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,500,000-1,750,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 30,000-50,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,200
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 2,000,000-2,200,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 2,000,000-2,400,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 300,000-500,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 10,000-30,000
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus equi, bacterial glycosaminoglycan polysaccharide
Sigma-Aldrich
Hyaluronic acid sodium salt from rooster comb, avian glycosaminoglycan polysaccharide
Sigma-Aldrich
Hyaluronic acid sodium salt from Streptococcus zooepidemicus, bacterial glycosaminoglycan polysaccharide